No significant effect of orally administered chemokine receptor I antagonist on intercellular adhesion molecule-3 expression in relapsing―remitting multiple sclerosis patients

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Multiple sclerosis 2010, Vol.16 (3), p.366-369
Hauptverfasser: REUSS, R, SCHREIBER, V, KLEIN, A, INFANTE-DUARTE, C, FILIPPI, M, PABST, W, POHL, C, OSCHMANN, P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 369
container_issue 3
container_start_page 366
container_title Multiple sclerosis
container_volume 16
creator REUSS, R
SCHREIBER, V
KLEIN, A
INFANTE-DUARTE, C
FILIPPI, M
PABST, W
POHL, C
OSCHMANN, P
description
format Article
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_22572056</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>22572056</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_225720563</originalsourceid><addsrcrecordid>eNqNjE1KBDEQhRtRcPy5Q21cNsTuidG1KLpx5X4oMpWe0uokpNLg7LyEB_FKnsQoHsDV-3h87x10q8u1c725ceaw8WiHfm2v7XF3ovpijHFutKvu8ymB8hQ5sMdYgUIgXyEFSAVF9oDbmSNrpUJb8Dua0ytHgkKeck0FHqHNcEo_DqQIHJvqSWQRLG29I-VWz0nIL0L9CPSWC-lvy7EdCWblOH29fxSaudbGMC9SOQuBeqGSlBUyVqZY9aw7CihK53952l3c3z3fPvQZ1aOEgtGzbnLhGct-MwzWDcZejf_1vgHlOWmf</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>No significant effect of orally administered chemokine receptor I antagonist on intercellular adhesion molecule-3 expression in relapsing―remitting multiple sclerosis patients</title><source>SAGE Complete A-Z List</source><creator>REUSS, R ; SCHREIBER, V ; KLEIN, A ; INFANTE-DUARTE, C ; FILIPPI, M ; PABST, W ; POHL, C ; OSCHMANN, P</creator><creatorcontrib>REUSS, R ; SCHREIBER, V ; KLEIN, A ; INFANTE-DUARTE, C ; FILIPPI, M ; PABST, W ; POHL, C ; OSCHMANN, P</creatorcontrib><identifier>ISSN: 1352-4585</identifier><identifier>EISSN: 1477-0970</identifier><language>eng</language><publisher>London: Sage Publications</publisher><subject>Biological and medical sciences ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Medical sciences ; Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis ; Neurology</subject><ispartof>Multiple sclerosis, 2010, Vol.16 (3), p.366-369</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4022</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22572056$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>REUSS, R</creatorcontrib><creatorcontrib>SCHREIBER, V</creatorcontrib><creatorcontrib>KLEIN, A</creatorcontrib><creatorcontrib>INFANTE-DUARTE, C</creatorcontrib><creatorcontrib>FILIPPI, M</creatorcontrib><creatorcontrib>PABST, W</creatorcontrib><creatorcontrib>POHL, C</creatorcontrib><creatorcontrib>OSCHMANN, P</creatorcontrib><title>No significant effect of orally administered chemokine receptor I antagonist on intercellular adhesion molecule-3 expression in relapsing―remitting multiple sclerosis patients</title><title>Multiple sclerosis</title><subject>Biological and medical sciences</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Medical sciences</subject><subject>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</subject><subject>Neurology</subject><issn>1352-4585</issn><issn>1477-0970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqNjE1KBDEQhRtRcPy5Q21cNsTuidG1KLpx5X4oMpWe0uokpNLg7LyEB_FKnsQoHsDV-3h87x10q8u1c725ceaw8WiHfm2v7XF3ovpijHFutKvu8ymB8hQ5sMdYgUIgXyEFSAVF9oDbmSNrpUJb8Dua0ytHgkKeck0FHqHNcEo_DqQIHJvqSWQRLG29I-VWz0nIL0L9CPSWC-lvy7EdCWblOH29fxSaudbGMC9SOQuBeqGSlBUyVqZY9aw7CihK53952l3c3z3fPvQZ1aOEgtGzbnLhGct-MwzWDcZejf_1vgHlOWmf</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>REUSS, R</creator><creator>SCHREIBER, V</creator><creator>KLEIN, A</creator><creator>INFANTE-DUARTE, C</creator><creator>FILIPPI, M</creator><creator>PABST, W</creator><creator>POHL, C</creator><creator>OSCHMANN, P</creator><general>Sage Publications</general><scope>IQODW</scope></search><sort><creationdate>2010</creationdate><title>No significant effect of orally administered chemokine receptor I antagonist on intercellular adhesion molecule-3 expression in relapsing―remitting multiple sclerosis patients</title><author>REUSS, R ; SCHREIBER, V ; KLEIN, A ; INFANTE-DUARTE, C ; FILIPPI, M ; PABST, W ; POHL, C ; OSCHMANN, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_225720563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Biological and medical sciences</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Medical sciences</topic><topic>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</topic><topic>Neurology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>REUSS, R</creatorcontrib><creatorcontrib>SCHREIBER, V</creatorcontrib><creatorcontrib>KLEIN, A</creatorcontrib><creatorcontrib>INFANTE-DUARTE, C</creatorcontrib><creatorcontrib>FILIPPI, M</creatorcontrib><creatorcontrib>PABST, W</creatorcontrib><creatorcontrib>POHL, C</creatorcontrib><creatorcontrib>OSCHMANN, P</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Multiple sclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>REUSS, R</au><au>SCHREIBER, V</au><au>KLEIN, A</au><au>INFANTE-DUARTE, C</au><au>FILIPPI, M</au><au>PABST, W</au><au>POHL, C</au><au>OSCHMANN, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>No significant effect of orally administered chemokine receptor I antagonist on intercellular adhesion molecule-3 expression in relapsing―remitting multiple sclerosis patients</atitle><jtitle>Multiple sclerosis</jtitle><date>2010</date><risdate>2010</risdate><volume>16</volume><issue>3</issue><spage>366</spage><epage>369</epage><pages>366-369</pages><issn>1352-4585</issn><eissn>1477-0970</eissn><cop>London</cop><pub>Sage Publications</pub></addata></record>
fulltext fulltext
identifier ISSN: 1352-4585
ispartof Multiple sclerosis, 2010, Vol.16 (3), p.366-369
issn 1352-4585
1477-0970
language eng
recordid cdi_pascalfrancis_primary_22572056
source SAGE Complete A-Z List
subjects Biological and medical sciences
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Medical sciences
Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
Neurology
title No significant effect of orally administered chemokine receptor I antagonist on intercellular adhesion molecule-3 expression in relapsing―remitting multiple sclerosis patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T23%3A03%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=No%20significant%20effect%20of%20orally%20administered%20chemokine%20receptor%20I%20antagonist%20on%20intercellular%20adhesion%20molecule-3%20expression%20in%20relapsing%E2%80%95remitting%20multiple%20sclerosis%20patients&rft.jtitle=Multiple%20sclerosis&rft.au=REUSS,%20R&rft.date=2010&rft.volume=16&rft.issue=3&rft.spage=366&rft.epage=369&rft.pages=366-369&rft.issn=1352-4585&rft.eissn=1477-0970&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E22572056%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true